TRIOBIMET 1 (Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg))

Triobimet 1mg/500mg/15mg Extended Release Tablet is an amalgamation of medicines designed to assist in managing blood sugar levels effectively. This medication is indicated for use alongside dietary modifications and physical activity to enhance glycemic control in adults with type 2 diabetes. It facilitates the appropriate use of insulin, which in turn aids in lowering blood sugar concentrations. It is imperative to adhere to the dosing and duration prescribed by your healthcare provider. This medication should be administered with meals to mitigate any gastrointestinal discomfort. In cases of a missed dose, it is advisable to take it promptly unless it is nearly time for the subsequent dose; in such instances, the missed dose should be omitted, and the usual schedule resumed without doubling the dose. An overdose may result in hypoglycemia, a condition characterized by abnormally low blood sugar levels. Individuals may experience hypoglycemia when this medication is combined with other antidiabetic agents, alcohol consumption, or skipping meals. Regular monitoring of blood glucose levels is essential while on this treatment. Additional frequently observed side effects may include but are not limited to nausea, diarrhea, abdominal discomfort, headaches, bone fractures, and respiratory infections. Prior to initiating therapy with this medication, it is crucial to inform your healthcare provider of any existing kidney, liver, or heart conditions. Pregnant or nursing women are advised to consult their physicians before starting this medication. Routine kidney function assessments are recommended before commencing treatment.